Tag: Motley Fool

The Tyro Payments Ltd (ASX: TYR) share price is rocketing higher after the company knocked back an unsolicited takeover bid.

A consortium of private equity investors put forward a $1.27 per share bid for total control of the financial technology company. That represents an enterprise value of $693.9 million.

The bid was rejected by the company this morning. It said the offer significantly undervalues it.

The Tyro share price is $1.235 at the time of writing, 25.08% higher than its previous close, after touching an intraday high of $1.295. That represents a 31.47% jump.

Let’s take a closer look at today’s news from the payments services provider.

Tyro share price leaps on rejected takeover bid

The Tyro share price is surging on news the company has rejected a near-$700 million takeover bid.

The offer was put forward by a consortium led by tech-focused investment firm Potentia Capital Management. The group also includes HarbourVest Partners, MLC Investments Limited, and The Construction and Building Unions Superannuation Fund.

Tyro’s board slapped the $1.27 per share offer away, saying:

The indicative proposal is materially below Tyro’s fundamental value and highly opportunistic given [it] is substantially below where Tyro’s share price has traded in the past 12 months.

The company also said the offer is highly conditional.

On top of that, Tyro pointed out its growth prospects and its increasing share of the Australian payments and business banking markets. It also said it expects its operating leverage will strengthen in the medium term and noted it’s well funded for growth.

Interestingly, the consortium secured the support of major Tyro shareholder Grok Ventures.

Readers might recognise Grok as the investment vehicle of Atlassian Corporation (NASDAQ: TEAM) co-founder Mike Cannon-Brooks. It was an integral piece of the puzzle that ultimately dismantled AGL Energy Limited (ASX: AGL)’s planned demerger.

The consortium struck a deal with Grok that would see the firm’s 12.5% stake in the company voted towards its bid.

Grok will also be blocked from acting on any competing proposals unless such a proposal is at least 25 cents greater than that of the most recent bid from the consortium.

The Tyro share price fell 66% between the start of 2022 and Wednesday’s close. At its current price, it’s down 57% year to date.

The post Tyro share price rallies 31% following rejected takeover bid appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 2 heart-breaking ASX shares finally turning it around: Morgans
• 3 ASX All Ords shares that leapt over 10% today
• Why did the Tyro share price surge 12% today?
• Why Deep Yellow, Nitro, Tyro, and Webjet shares are storming higher
• Why A2 Milk, Lovisa, McMillan Shakespeare, and Tyro are storming higher

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Atlassian and Tyro Payments. The Motley Fool Australia has recommended Tyro Payments. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/aqOtNGI

The Electro Optic Systems Hldg Ltd (ASX: EOS) share price has returned from its lengthy suspension and crashed deep into the red.

In morning trade, the embattled defence and space systems company’s shares were down as much as 35% to 47 cents. It has since recovered a touch and is currently down 23% to 55.5 cents.

Investors have been selling down the Electro Optic Systems share price following the eventual release of its delayed half-year results.

Electro Optic Systems share price crashes on half-year update

• Revenue down 45% to $53.8 million
• EBITDA loss of $34.7 million
• Net loss after tax increased from $11.7 million to $99 million
• Financing agreement signed with Soul Patts
• FY 2022 guidance being reassessed

What happened during the half?

For the six months ended 30 June, Electro Optic Systems reported a 45% decline in revenue to $53.8 million. Management blamed this on delayed revenue recognition arising from supply chain disruptions.

Things were even worse further down the income statement, with the company reporting a whopping $99 million loss after tax for the six months. This was a ~750% increase on the $11.7 million loss it recorded a year earlier.

However, it is worth noting that $54.4 million of this loss is attributable to the impairment of assets and onerous contracts held in SpaceLink.

Spacelink is the company’s satellite communications business which has an almighty task of competing against Elon Musk’s Starlink and Apple’s new satellite-connected handsets.

Though, whether the company will hold onto the cash-burning Spacelink business, only time will tell. Management revealed that it continues to explore opportunities to realise value from the SpaceLink assets and remains in active negotiations with potential partners and purchasers.

The rest of the loss has been blamed on the company having a cost structure larger than required for the current level of revenue. Positively, this is being addressed as part of the organisational restructure being implemented following a strategic review.

Restructure

Electro Optic Systems revealed that it is adopting a leaner structure that will prioritise existing business lines that are profitable and respond to customer procurement activity rather than anticipating requirements through customer planning documents.

Significant management changes, reductions in workforce, and a simplified strategy and business plan are also in the works. Full-year cost savings of at least $20 million are expected from these changes.

To support it through these challenging times, major shareholder Washington H. Soul Pattinson and Co. Ltd (ASX: SOL) has agreed to refinance the $35 million Roadnight debt facility that was due to expire on 6 September 2022 and extended the current maturity date to 26 September 2022.

Management expects to seek further extensions from Soul Patts as part of a staged refinancing of the company. Though, it acknowledges that there can be no guarantee that such extensions will be obtained.

Soul Patts has also agreed to provide the company with a $20 million working capital facility.

Outlook

Electro Optic Systems was previously guiding to FY 2022 revenue at or above 2021 levels of $212 million.

However, in light of the challenging first half and supply chain uncertainties, the company is reviewing its guidance and will provide an update at a later date.

The post Electro Optic Systems share price crashes 35% after first-half shocker appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the Electro Optic Systems share price frozen today?
• Why has the Electro Optic Systems share price soared 16% in 2 days?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Electro Optic Systems Holdings Limited and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Electro Optic Systems Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/7tbSP3e

With the unwinding of the high-growth/tech trade of the past two years, many biotechnology names suffered equally in nasty selloffs this year.

Shares of Mesoblast Ltd (ASX: MSB) have taken a hit in 2022 having slipped more than 42% into the red this year to date.

Shares of the regenerative medicine player are currently at 84 cents apiece in early trading on Thursday, gaining the 3% they lost in yesterday’s session.

What’s Mesoblast been up to?

It was a busy period in the last financial year for Mesoblast, especially in its liaison with the US Food and Drug Administration (FDA).

Mesoblast has made, and is set to make, a host of submissions to the FDA regarding its lead drug candidates, Remestemcel-L and Rexlemestrocel-L.

It intends to resubmit a biologics license application (BLA) with the FDA this quarter for the approval of Remestemcel-L in treating children with steroid-resistant acute graft-versus-host-disease (SR-aGVHD). It is aiming for this approval in early 2023.

Meanwhile, Mesoblast also plans to meet with the FDA in the next quarter under its existing regenerative medicine advanced therapy (RMAT) designation to discuss Rexlemestrocel-L.

They will look over data from the company’s recent phase 3 trial of 565 patients with heart failure condition HFrEF.

Rexlemestrocel-L also “gained alignment” with the FDA last period on key metrics for a pivotal phase 3 clinical trial in patients with chronic low back pain (CLBP) associated with disc pathology.

This follows on from the first phase 3 trial covering the same condition and Mesoblast hopes to replicate favourable results produced there.

The company also plans to have received clearance from the FDA by the end of 2022 so it can commence the pivotal trial.

As such, it will be a busy few months for Mesoblast as it looks to progress through this next round of trials in both of its leading drug segments.

In the last 12 months, the Mesoblast share price has faltered 54% into the red.

The post Looking to buy Mesoblast shares? Here’s the latest on where the ASX biotech is at with the FDA appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Mesoblast share price lifts 5% despite hefty loss
• Why has the Mesoblast share price tumbled 10% so far in August?
• These are the 10 most shorted ASX shares
• Why Block, CBA, Mesoblast, and NAB shares are dropping today
• Mesoblast share price slides 8% following $65m capital injection

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/8liJy4A

The Woodside Energy Group Ltd (ASX: WDS) share price has crashed deep into the red on Thursday morning.

In early trade, the energy producer’s shares are down 7.5% to $31.43.

This compares unfavourably to the ASX 200 index, which is up 0.5% at the time of writing.

Why is the Woodside share price crashing?

There have been a couple of catalysts for the weakness in the Woodside share price on Thursday.

The first is a very poor night of trade for oil prices. Both Brent and WTI crude oil prices sank over 5% to seven-month lows amid concerns over recession risks and the release of downbeat Chinese trade data.

Fellow energy producers Santos Ltd (ASX: STO) and Beach Energy Ltd (ASX: BPT) are also dropping on the news.

What else?

Also weighing particularly heavily on the Woodside share price is its upcoming dividend payment.

Last month, the company released its half year results and reported a huge increase in its earnings. This allowed the Woodside board to reward its shareholders handsomely with a big dividend hike.

For the half, Woodside declared a US$1.09 per share interim dividend, up from 30 US cents per share a year earlier. This equated to A$1.58 per share based on the exchange rates at the time and represented a 4.6% dividend yield at yesterday’s close price.

This morning, Woodside’s shares have traded ex-dividend for this interim payout. This means that the rights to the dividend payment now remain with the seller and won’t transfer to buyers of its shares between now and the payment date.

In light of this, the Woodside share price has dropped to reflect this. After all, if you were buying shares you wouldn’t want to pay for something you won’t receive.

Eligible shareholders can now look forward to receiving this dividend in just under a month on 6 October.

The post Why is the Woodside share price crashing 7% today? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 5 things to watch on the ASX 200 on Thursday
• Why is the Woodside share price on the slide today?
• Hoping to pocket the monster Woodside dividend? Read this
• 5 things to watch on the ASX 200 on Wednesday
• What happened to Woodside shares on Tuesday?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/86akMKo

The Commonwealth Bank of Australia (ASX: CBA) share price could get a boost over the long term from ongoing growth in its business banking division.

There are many banks in Australia. Some are huge like CBA, National Australia Bank Ltd (ASX: NAB), Westpac Banking Corp (ASX: WBC), and Australia and New Zealand Banking Group Ltd (ASX: ANZ).

Whereas others are a bit smaller, but still pretty big, like Bank of Queensland Limited (ASX: BOQ), Bendigo and Adelaide Bank Ltd (ASX: BEN), and MyState Limited (ASX: MYS).

Just how big are the biggest banks? According to the ASX:

CBA has a market capitalisation of around $160 billion.

NAB has a market capitalisation of $92.75 billion.

Westpac has a market capitalisation of $73 billion.

ANZ has a market capitalisation of $66.6 billion.

As you can see, CBA is by far the biggest bank and it has plans to become even bigger.

Focused on business banking growth

In its FY22 result, CBA reported that it achieved home lending growth of 7.4% and 13.2% growth in household deposits.

But, in percentage terms, the business segment of its operations grew even quicker. Business lending rose by 13.6% (or $15.4 billion in dollar terms) and business deposits increased by 15.1% (or $23.9 billion).

In its annual report, CBA said that its goal is to build Australia’s leading business bank. It’s focused on continuing to differentiate its transaction and merchant banking propositions, and digitising its business banking experience.

It wants to be the main bank of choice for business customers by partnering with them, proactively meeting more of their needs, and delivering a superior customer experience.

New leadership team member

CBA announced earlier this week the appointment of independent non-executive director Lyn Cobley, starting 1 October 2022.

Cobley has more than 30 years of experience in financial services. Notably, she’s the former CEO of Westpac’s institutional banking business and chair of Westpac’s Asia advisory board, as well as group treasurer of CBA.

CBA Chair Paul O’Malley said:

On behalf of the board, I am delighted to announce Lyn’s appointment, and to welcome her breadth of financial services experience in her role as a non-executive director of CBA.

What to make of this

CBA is already growing at a good pace in its business banking, but Cobley may be able to provide some valuable expertise for the board and the business. Business banking growth could also be good for the CBA share price.

Motley Fool Australia chief investment officer Scott Phillips spoke on Nine’s Late News on Tuesday night about this appointment. He said:

This is fascinating…because CBA’s done a really good job over the past year or two of really diving deeply into the business market.

It’s always been the king of the kids when it comes to the mortgage market, the property market, but business lending and business relationships in general are more the remit of NAB and Westpac in-particular. Institutional banking is a really important part of the Commonwealth Bank growth strategy and this does bolster their activities and their expertise in this area.

CBA share price snapshot

Over the last month, CBA shares have dropped by 8%.

The post Could this help give the CBA share price an even bigger jump on its ASX counterparts? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why is the NAB share price diving more than the other big 4 ASX banks today?
• Why rising rates are a ‘sugar hit’ for ASX 200 bank shares: Macquarie
• Rates go up, and CBA beefs up its business cred. Scott Phillips on Nine’s Late News
• Own CBA shares? Here’s the bank’s warning on rapid RBA rate hikes
• How might falling house prices impact the CBA share price?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo and Adelaide Bank Limited. The Motley Fool Australia has recommended Westpac Banking Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/HKUvxLQ

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Many investors have become notably more bearish on Netflix (NASDAQ: NFLX) lately, but you wouldn’t know that by looking at the stock’s performance on Wednesday. It surged nearly 5% higher on the day, thanks to an article in a top financial news outlet highlighting some potentially beneficial moves it’s making, and an analyst recommendation upgrade. 

So what

The article was published Wednesday morning in the finance world’s newspaper of record, The Wall Street Journal. Citing “people familiar with the matter,” the report states that Netflix is actively reviewing its operations for areas in which it can cut costs. Among other activities currently being assessed are its real estate holdings and cloud computing expenses.

In the personnel sphere, the article’s sources say the company has actively been hiring more junior staff, presumably because such individuals require lower salaries.

All told, Netflix’s operating expenses were $23.5 billion in 2021, which was up 15% from the 2020 level. Meanwhile, the streaming video king’s subscriber count has been falling lately. The company has already said that it will cut spending on both content and non-content costs.

Netflix has not yet officially commented on the Journal article.

Now what

Meanwhile, Macquarie analyst and longtime Netflix tracker Tim Nollen lifted his recommendation on the stock. He now feels it’s worthy of a neutral rating, rather than his previous tag of underperform (sell). He’s also lifting his price target substantially, boosting it to $230 per share from the preceding $170.

Nollen is basing this on Netflix’s plan to introduce an ad-supported subscription tier. He wrote in a new note that the company could draw $3.6 billion in revenue from this, although that tally shakes down to $1.1 billion when factoring in the almost certain lower subscription prices for such a tier.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Netflix was a star stock today appeared first on The Motley Fool Australia.

(function() { function setButtonColorDefaults(param, property, defaultValue) { if( !param || !param.includes(‘#’)) { var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0]; button.style[property] = defaultValue; } } setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’); setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’); setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’); })()

More reading

• What makes ‘Dividend Aristocrats’ a great investment for you?
• 3 great foreign companies to invest in right now
• Did Bill Ackman give up on Netflix too soon?

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netflix. The Motley Fool Australia has recommended Netflix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/vylbIHW

If you’re a fan of investing in growth shares, then you may want to look at the ASX shares named below that have been tipped as buys by analysts at Morgans.

Here’s why the broker thinks these are some of the best growth shares on the Australian share market right now:

Lovisa Holdings Ltd (ASX: LOV)

Morgans is a big fan of this fashion jewellery retailer and believes it has a material global growth opportunity. The broker also highlights that its highly experienced CEO has been there and done this before with other brands. The broker commented:

LOV has a substantial multi-year global rollout opportunity across four continents. This opportunity has been materially boosted by the acquisition last year of beeline, which took LOV into several new European markets (notably Germany) and accelerated its expansion in France. We think LOV’s products fill an underserved niche, offering good quality fashion jewellery at prices that are attainable to the target demographic. The recent appointment of Victor Herrero as CEO, replacing Shane Fallscheer, provides a clue as to the extent of LOV’s global ambition, and its impatience to realise that ambition. The next few years will be worth watching.

Its analysts have an add rating and $24.50 price target on the company’s shares.

Pro Medicus Limited (ASX: PME)

Another ASX growth share that Morgans believes is destined for big things is Pro Medicus. It is a provider of industry leading health imaging technology. The broker highlights that the company is exposed to favourable long-term industry tailwinds and has contracts with some of the biggest and brightest healthcare companies. It said:

Pro Medicus is a leading healthcare end-to-end imaging software and service provider, servicing a number of the world’s largest imaging centres and health care groups. We like the space, with high single digit organic volume growth and long-term industry tailwinds. Profitability in the business is backed up by long-term contracted revenues with some of the world’s largest hospital systems and growing pipeline of tenders which we view will provide continued growth over the medium to long term. We view the business as best-in-class as it heads into CY22 with a step-change in billable contracts following the significant volume and value of contracts signed over the last 12-18 months. The recent market weakness in high growth tech names has provided an opportunity for reasonable entry points.

Morgans has an add rating and $58.18 price target on Pro Medicus’ shares.

The post Morgans names 2 of the best ASX growth shares to buy appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Analysts say these exciting ASX growth shares have at least 20% upside
• 3 ASX All Ords shares smashing new highs on Monday
• Why Allkem, Capricorn Metals, Lovisa, and Pilbara Minerals shares are rising today
• Here’s why the Lovisa share price leapt 8% on Monday
• Why these 3 ASX shares could be in for a massive boost this month

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has positions in and has recommended Pro Medicus Ltd. The Motley Fool Australia has recommended Lovisa Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Ozm4cYG

If you’re looking for ASX dividend shares to buy, then you may want to check out the two listed below.

Both of these ASX dividend shares have recently been named as buys by analysts. Here’s why they could be worth considering today:

Baby Bunting Group Ltd (ASX: BBN)

The first ASX dividend share for income investors to consider is leading baby products retailer Baby Bunting.

It has a dominant position in a less discretionary side of the retail industry, which bodes well for its growth in the current environment.

Analysts at Citi are positive on the company and currently have a buy rating and $5.62 price target on its shares. The broker was pleased with its expansion into higher margin areas and the new national distribution centre.

Looking ahead, the broker appears to believe the company is well-placed for growth over the long term and is forecasting fully franked dividends per share of 18 cents in FY 2023 and then 22 cents in FY 2024. Based on the current Baby Bunting share price of $4.15, this will mean yields of 4.3% and 5.3%, respectively.

Centuria Industrial REIT (ASX: CIP)

Another ASX dividend share to look at is Centuria Industrial. It is the largest domestic pure play industrial REIT on the Australian share market.

This has been a great part of the property market to be, with demand for industrial space growing strongly in recent years. In fact, last month when Centuria Industrial released its full year results, it revealed that its occupancy rate increased to ~99% with a weighted average lease expiry of 8.3 years. This supported a 22% increase in funds from operations to $111.7 million.

Macquarie is bullish on Centuria Industrial and currently has an outperform rating and $3.69 price target on its shares.

As for dividends, the broker is expecting dividends per share of approximately 16 cents in FY 2023 and FY 2024. Based on the current Centuria Industrial share price of $3.02, this will mean yields of 5.3% for investors.

The post Experts say these ASX dividend shares are buys today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ASX All Ordinaries shares going ex-dividend today
• Experts name 2 top ASX dividend shares to buy with 4%+ yields
• After seeing their reports, I think these 2 ASX 300 shares are buys
• Leading brokers name 3 ASX shares to buy today
• Why Baby Bunting, PointsBet, ResMed, and Suncorp shares are dropping today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Baby Bunting. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/4Vc0Nlt

ASX dividend shares that pay bigger dividends in 2023 could be really interesting to some investors.

It might be hard for some companies to grow their profit and dividends in this period of rising inflation as higher costs like wages, rent and supply chains weigh on businesses.

But, growing dividends may be exactly what investors are looking for. With so many products and services becoming more expensive due to inflation, higher investment income could be the best way to combat that.

There are plenty of businesses that would like to grow their dividends. But there are a few dividend beasts that have committed to paying bigger payouts to shareholders.

Rural Funds Group (ASX: RFF)

Rural Funds is a real estate investment trust (REIT) that owns a diversified portfolio of farms across a range of industries. They include cattle, cropping (cotton and sugar), macadamias, almonds and vineyards.

The ASX dividend share aims to grow its distribution by 4% per annum.

It has forecast that the total distribution in FY23 will be 12.2 cents, which includes 47 cents of franking credits.

Three different factors contribute to this distribution growth.

The first is organic rental growth thanks to rental growth built into the contracts with tenants. Some of the increases are linked to CPI inflation, some are fixed (with a 2.5% annual increase) and some have infrequent market reviews.

The second strategy is investing in its farms. Sometimes that’s just some sort of investment like adding water access or something of that nature. Other times it involves changing a farm to a more profitable use or planting crops. For example, it is currently working on a $165 million development for macadamias.

Finally, the REIT can make the occasional value-adding acquisition to the portfolio.

Including franking credits, the projected Rural Funds distribution yield for FY23 is 4.9%.

Duxton Water Ltd (ASX: D2O)

This ASX dividend share is another that’s linked to the agricultural sector. But, like Rural Funds, its success isn’t directly linked to food prices.

It’s a business that owns water entitlements and can be leased to farmers for long-term leases or for short periods of time.

Duxton thinks that water entitlement values could remain supported and perhaps grow as more water-hungry permanent crops are planted, like almonds.

It’s expecting to grow its dividend to 7.1 cents per share in FY23. At the current Duxton Water share price, its expected this ASX dividend share will pay a grossed-up dividend yield of 6%.

Sonic Healthcare Limited (ASX: SHL)

Sonic is a leading ASX healthcare share that has a “progressive dividend policy”.

In FY22 the business grew its total dividend by 10% to $1. Sonic Healthcare also launched a share buyback.

It’s benefitting from steady revenue growth (and operating leverage) of its base business which is predominately pathology. The ASX dividend share has a presence in multiple countries including the United States, Germany and Australia.

I also like that the business has used the cash flow boost from COVID testing over the last couple of years. It has made acquisitions and locked in more earnings for future years, rather than treating it as a one-off boost.

The company’s link-up with artificial intelligence business Harrison.ai could develop into a very interesting partnership in the coming years.

While it hasn’t provided specific dividend guidance, it’s worth noting that the FY22 dividend would equate to a grossed-up dividend yield of 4.4% in FY23. But Sonic said that its “progressive dividend strategy [is] expected to continue in FY23 and beyond”.

The post Dividend beasts: 3 ASX shares forecasting higher dividends in 2023 appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ASX shares I’ll be buying and holding for years to come
• Batteries and water: Experts name 2 ASX shares you can’t ignore
• How I’d invest $50,000 in ASX dividend shares for retirement, if I had to start from scratch
• 5 ASX 200 shares turning ex-dividend tomorrow
• Analysts name 2 blue chip ASX 200 shares to buy now

Motley Fool contributor Tristan Harrison has positions in DUXTON FPO and RURALFUNDS STAPLED. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended RURALFUNDS STAPLED. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/475IP1x

So far this month, we’ve seen a swarm of companies in the S&P/ASX 200 Index (ASX: XJO) turn ex-dividend.

Compared to other days this week, tomorrow will be a rather quiet affair with only two ASX 200 shares going ex-dividend. 

In other words, as of tomorrow, these shares will no longer be trading with entitlements to their respective upcoming dividend payments.

Let’s check them out.

Nine Entertainment Co Holdings Ltd (ASX: NEC)

Today will be the last day to snap up Nine Entertainment’s fully franked final dividend of 7 cents. It will be paid on 20 October.

FY22 was another year of growth for Nine. Starting at the top line of the income statement, double-digit growth in each of its divisions contributed to 15% revenue growth, which came in at $2.7 billion.

Stan was Nine’s fastest-growing business, with growth in active subscribers and average revenue per user (ARPU) leading to a 22% jump in revenue, which reached $381 million. However, Stan’s earnings before interest, tax, depreciation and amortisation (EBITDA) fell by 28% to $29 million, primarily reflecting increased investment in Stan Sport.

Across the group, EBITDA climbed 24% to $701 million as the all-important broadcast division delivered EBITDA of $401 million, up 21% from the prior year.

Notably, Nine’s digital earnings grew by 47% in FY22 and now account for more than half of the group’s EBITDA.

This earnings growth helped Nine to declare record total dividends of 14 cents in FY22, up 33% from the prior year.

Nine shares are currently sporting a trailing dividend yield of 6.4%, which grosses up to 9.2% including franking credits.

Speaking of sport, Nine made a play for the AFL broadcasting rights that were up for grabs from 2025 onwards. But ultimately, the AFL decided to stick with current partners Seven West Media Ltd (ASX: SWM), Foxtel, and Telstra Corporation Ltd (ASX: TLS); signing a seven-year deal worth $4.5 billion.

WiseTech Global Ltd (ASX: WTC)

WiseTech is the other ASX 200 share turning ex-dividend tomorrow.

Unlike Nine, WiseTech is more of an ASX growth share that offers shareholders token dividends.

The company recently announced a fully franked final dividend of 6.4 cents, which is dwarfed by WiseTech’s current share price of $57.53.

WiseTech posted revenue of $632 million in FY22, up 25% on the prior year and at the top end of guidance.

Revenue from the company’s flagship CargoWise solution grew by 35% to $448 million. This was underpinned by large global freight forwarder rollouts, new customer wins, and increased usage from existing customers.

Impressively, the ASX 200 tech share improved its EBITDA margin by nine percentage points to 50%. The company said this reflected enhanced operating leverage, the benefits of exceeding its cost reduction program targets, and pricing offsetting inflation.

As a result, EBITDA jumped by 54% to $319 million while underlying net profit after tax (NPAT) surged 72% to $182 million.

The company expects this momentum to roll into FY23. It’s guiding for revenue growth in the range of 20% to 23% and EBITDA growth in the range of 21% to 30%.

In terms of dividends, WiseTech declared total dividends of 11.15 cents in FY22, up 72% from the prior year. 

This represents a dividend payout ratio of 20% of underlying NPAT and puts WiseTech shares on a meagre trailing dividend yield of 0.2%.

The post 2 ASX 200 shares turning ex-dividend tomorrow appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• ASX 200 tech shares are getting hammered on Monday. Here’s why
• Here are the top 10 ASX 200 shares today
• Nine Entertainment hikes full-year dividend by 33% as profits surge higher
• Nine Entertainment share price takes off after 71% profit boost and ‘record’ dividend
• ‘Bright outlook’: Expert picks 2 ASX shares that touch Aussies everyday

Motley Fool contributor Cathryn Goh has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended WiseTech Global. The Motley Fool Australia has positions in and has recommended Telstra Corporation Limited and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/CYTmWAO